OAKLAND, Calif.–(BUSINESS WIRE)–Riffyn, provider of the industry’s most widely adopted cloud system for intelligent process design, closed another record-breaking year. In 2020, for the fourth year in...
Emerging technologies
Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs
Financing will support advancement of lead HIV potential cure program into clinical development SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of...
